Disease and disorder research has been conducted in relation to the Mammary Gland Specification Pathway and Ectopic Tissue. The study of the Mammary Gland Specification Pathway has been mentioned in research publications which can be found using our bioinformatics tool below. The Mammary Gland Specification Pathway has been researched in relation to Gland Morphogenesis, Gland Development, Mammary Gland Morphogenesis, Mammary Gland Development. The Mammary Gland Specification Pathway complements our catalog of research reagents including antibodies and ELISA kits against SCARAMANGA, SKA, EGFR, ERBB4, NRG3.
Top Research Reagents
We have 1897 products for the study of the Mammary Gland Specification Pathway that can be applied to Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.
![Western Blot: LEF1 Antibody (3H5) [H00051176-M01] - LEF1 monoclonal antibody (M01), clone 3H5 Analysis of LEF1 expression in MES-SA/Dx5.](https://images.novusbio.com/fullsize/LEF1-Antibody-3H5-Western-Blot-H00051176-M01-img0009.jpg)
![Western Blot: LEF1 Antibody (3H5) [H00051176-M01] - Analysis of LEF1 over-expressed 293 cell line, cotransfected with LEF1 Validated Chimera RNAi ( Cat # H00051176-R01V ) (Lane 2) or non-transfected control (Lane 1). Blot probed with LEF1 monoclonal antibody (M01), clone 3H5 (Cat # H00051176-M01 ). GAPDH ( 36.1 kDa ) used as specificity and loading control.](https://images.novusbio.com/fullsize/LEF1-Antibody-3H5-Western-Blot-H00051176-M01-img0006.jpg)
